Is Vertex Stock Still a Good Buy?
Over the past ten years or so, Vertex Pharmaceuticals (NASDAQ:…
Sell
50
KNEVF Quote, Financials, Valuation and Earnings
Last price:
$8.03
Seasonality move
:
-24.03%
Day range:
$8.03 - $8.03
52-week range:
$3.18 - $11.71
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.63x
Volume:
800
Avg. volume:
617
1-year change:
-24.92%
Market cap:
$2.3B
Revenue:
-$247.9M
EPS (TTM):
-$1.85
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Kinnevik AB has -- downside to fair value with a price target of -- per share.
KNEVF vs. S&P 500
-
Over the past 5 trading days, Kinnevik AB has overperformed the S&P 500 by 3.94% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Kinnevik AB does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Kinnevik AB revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Kinnevik AB reported revenues of -$284.8M.
Earnings Growth
-
Kinnevik AB earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Kinnevik AB reported earnings per share of -$1.03.
Enterprise value:
2.4B
EV / Invested capital:
0.63x
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
-0.17x
EV / Free cash flow:
-122.89x
Price / Operating cash flow:
77.70x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
-11.79%
Net Income Margin (TTM):
--
Return On Equity:
-13.5%
Return On Invested Capital:
-12.49%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | -$1.2B | -$707.3M | -$514.9M | -$22.3M | -$284.8M | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -$4.37 | -$2.52 | -$1.85 | -$0.08 | -$1.03 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $322M | $74.7M | $307.5M | $412.3M | $61.4M | |
| Total Assets | $14B | $7.8B | $5.8B | $5B | $3.9B | |
| Current Liabilities | -- | -- | -- | -- | -- | |
| Total Liabilities | $464.1M | $494.1M | $458.7M | $479.8M | $316M | |
| Total Equity | $13.5B | $7.3B | $5.4B | $4.5B | $3.6B | |
| Total Debt | $336.7M | $380.3M | $339M | $333.6M | $205.5M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $321.4M | $55.8M | -$19.7M | -$12.6M | -$11.4M | |
| Cash From Investing | $232.8M | -$79.2M | $548.1M | $208.1M | -$85.2M | |
| Cash From Financing | $9.2M | -- | -$744.8M | -- | -$140.6M | |
| Free Cash Flow | $321.4M | $55.8M | -$19.7M | -$12.6M | -$11.4M | |
KNEVF
Sector
Market Cap
$2.3B
$603.7M
Price % of 52-Week High
68.57%
84.45%
Dividend Yield
0%
2.05%
Shareholder Yield
--
3.98%
1-Year Price Total Return
-24.92%
9.07%
Beta (5-Year)
--
0.555
Dividend yield:
0%
Annualized payout:
$2.21
Payout ratio:
-117.25%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$7.71
200-day SMA
Buy
Level
$7.51
Bollinger Bands (100)
Buy
Level
6.85 - 8.03
Chaikin Money Flow
Sell
Level
-4.4K
20-day SMA
Buy
Level
$7.24
Relative Strength Index (RSI14)
Buy
Level
67.61
ADX Line
Buy
Level
31
Williams %R
Sell
Level
-8.3333
50-day SMA
Buy
Level
$7.55
MACD (12, 26)
Buy
Level
0.18
25-day Aroon Oscillator
Buy
Level
56
On Balance Volume
Neutral
Level
29.7K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.1006)
Buy
CA Score
(Annual)
Level (1.1054)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (4)
Sell
Ohlson Score
Level (1.0508)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Kinnevik AB is an operationally oriented investment group with an entrepreneurial focus on building digital brands. It concentrates its growth-style investment efforts on four sectors: TMT, e-commerce and marketplaces, Healthcare and financial services. Nearly all of its capital is committed to the communication e-commerce and marketplace sectors. The group, through its various subsidiaries, is geographically diversified and operationally present in over 80 countries. Kinnevik's bias is toward investing in emerging markets because of the opportunity afforded by these markets' reliance on legacy products and services. A key component of its is to create consumer choice of solutions in markets where supply may have been previously constrained.
Stock Forecast FAQ
In the current month, KNEVF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The KNEVF average analyst price target in the past 3 months is --.
-
Where Will Kinnevik AB Stock Be In 1 Year?
According to analysts, the consensus estimate is that Kinnevik AB share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Kinnevik AB?
Analysts are divided on their view about Kinnevik AB share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Kinnevik AB is a Sell and believe this share price will rise from its current level to --.
-
What Is Kinnevik AB's Price Target?
The price target for Kinnevik AB over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is KNEVF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Kinnevik AB is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of KNEVF?
You can purchase shares of Kinnevik AB via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Kinnevik AB shares.
-
What Is The Kinnevik AB Share Price Today?
Kinnevik AB was last trading at $8.03 per share. This represents the most recent stock quote for Kinnevik AB. Yesterday, Kinnevik AB closed at $8.03 per share.
-
How To Buy Kinnevik AB Stock Online?
In order to purchase Kinnevik AB stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Okta Stock Finally Gaining Investor Confidence?
Given how digital transformation has proliferated, cyberattacks have also been…
Is The Trade Desk the Best Advertising Stock Now?
The worldly backdrop is now shrouded in heavy uncertainty and…
Stock Ideas
Buy
59
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
55
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
85
HIMS alert for Apr 30
Hims & Hers Health [HIMS] is down 5.48% over the past day.
Buy
54
EAT alert for Apr 30
Brinker International [EAT] is down 1.82% over the past day.
Sell
16
NSP alert for Apr 30
Insperity [NSP] is down 3.3% over the past day.
